Dose
Dose June 2026
Dose is acquiring highly focused liver and cholesterol traffic, but the store still asks too many visitors to orient themselves before the strongest proof appears. This roadmap concentrates on moving trust, clinical evidence, and higher-value merchandising closer to the decision point without adding heavy new friction to slow mobile pages.
Homepage Hero Path Simplification
Make the homepage hero behave like the paid acquisition funnel. Lead with one dominant liver CTA, then keep cholesterol as a secondary text path so users do not hit the site and immediately face two equal next steps.
Homepage Proof Strip Directly Under Hero
Surface the trust assets users need before they scroll into the rest of the page. Pull review scale and top press mentions into a tight strip below the hero CTA so the strongest reassurance is visible earlier.
Collection Tiles With Ratings and Benefit Labels
Make browse-stage decisions easier by adding proof and product framing on the collection cards themselves. Each tile should communicate why the product matters before the user clicks through to the PDP.
Pin the Bundle Above Single-SKU Merchandising
Move the highest-value bundle into the first major shoppable position so users see a stronger order-building option before they move into single-SKU browsing. The collection already supports bundles, but they appear too low in the flow.
PDP Subscription Decision Simplifier
Clarify the tradeoff between subscription and one-time purchase before the user reaches the selector. A compact comparison block can make the current preselected subscription feel easier to understand and easier to justify.
Pull Clinical Outcomes Into the Buy Box
Bring the strongest quantified study outcomes into the first purchase block so visitors do not have to scroll down to reach the most persuasive evidence. The page already contains the proof. It just appears too late.
Advertorial Landing Page Early Buy Box
Introduce a compact buy box much earlier on the liver advertorial page so paid visitors can commit while interest is still high. The existing page spends too much of the early experience in explanation mode before the offer returns.
Cart Drawer Complementary Add-On Module
Use the empty center space in the cart drawer for a complementary add-on module that helps users complete their routine. The current cart already includes a subscription and a free gift, so the next opportunity is a light AOV lift before checkout.
What is most likely suppressing performance right now
- Paid traffic is highly product-specific, but the homepage still asks too many users to choose their own path.
- The strongest trust assets and quantified clinical proof often appear below the first decision point instead of inside it.
- The collection page is visually polished but underpowered on browse-stage proof and bundle prioritization.
- The cart drawer already proves offer intent with subscription and a free gift, yet leaves meaningful AOV space unused.
- Mobile performance is weak on both the homepage and PDP, so even small UX friction carries extra cost.
Data Sources
Meta Ads & Landing Pages
- Paid social messaging is tightly focused on liver support and 30% off subscription-driven offers.
- The paid landing pages are narrower and more direct than the homepage experience.
- The advertorial-style liver page delays the product moment longer than the other paid landing pages.
Google Ads Transparency
- Search ads span both liver and cholesterol support, with concrete product and outcome-led language.
- Offer framing is prominent, especially first-subscription savings.
- The acquisition mix reinforces the need for faster self-sorting and stronger proof on arrival pages.
PageSpeed / Core Web Vitals
- The homepage mobile performance score is weak, which raises the cost of any extra above-the-fold friction.
- The cholesterol PDP is also slow on mobile, so purchase-proof changes should stay lightweight and high leverage.
- The best opportunities here come from reordering existing evidence, not adding large new modules.
Site Screenshots
- The homepage splits attention early between liver and cholesterol instead of mirroring the narrower paid funnel.
- The collection page emphasizes aesthetics and category structure more than product proof.
- The PDP contains strong proof assets, but some of the most persuasive evidence sits below the buy box.
- The cart drawer shows unused space between the active line items and checkout.
Site Structure Summary
- The site clearly supports category entry points across liver, cholesterol, and skin.
- The saved structure also confirms dedicated PDP and paid landing-page paths already exist for focused traffic.
- This makes message alignment and proof placement more important than broad structural redesign.
Reviews & UGC
- The external review artifact is limited, so broad voice-of-customer claims should stay restrained.
- Even with that limitation, visible on-site review counts remain an important proof asset that can be surfaced earlier.
- The recommendation set leans on proof placement rather than unsupported review-quality claims.
